Device Industry Mindful Of AHRQ Cost-Effectiveness Agenda, Due June 8

The device industry will discuss with AHRQ the need to consider long-term costs of new technology underutilization as the agency develops its cost-effectiveness research agenda

More from Archive

More from Medtech Insight